Johnson & Johnson

NYSE: JNJ
$160.09
-$1.51 (-0.9%)
Closing Price on October 29, 2024

JNJ Articles

The top analyst upgrades, downgrades and initiations seen on Thursday include Hasbro, Johnson & Johnson, Mattel, MetLife, United Rentals, United Technologies and Williams Companies.
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Johnson & Johnson offer disappointing 2017 outlook and announce that it is reviewing options, including possible sales, of its diabetes businesses.
24/7 Wall St. has put together a preview of Intel, Verizon, Chevron and the other Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
President-elect Donald Trump has spent a great deal of time on Twitter attacking American companies such as Boeing, General Motors and Ford.
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
December 12, 2016: Markets opened mixed Monday as traders position themselves for the FOMC meeting announcement due on Wednesday. An early 4% spike in crude oil moderated later in the day, but oil...
At the end of each year, investors look for opportunities and safe harbors to park their money for the year ahead. Investors who love dividends often consider the so-called Dogs of the Dow.
It turns out that 11 of the 30 Dow Jones Industrial Average stocks have a consensus price target that calls for more than 10% upside in the coming 12 months, and that is without considering dividends.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news of note, so this may just be a pause in an equity price run-up that has been on...
Solar energy adoption among large U.S. corporations has grown from a total installed base of 300 megawatts (MW) in 2012 to more than 1,000 MW this year. The total represents 16% of all...
Outside of Warren Buffett being one of the richest men alive and being considered the greatest investor of modern times, there have been many key changes in the Buffett stocks over recent quarters.
With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little.
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.